Globus Medical
GMED
373 hedge funds and large institutions have $4.85B invested in Globus Medical in 2021 Q4 according to their latest regulatory filings, with 49 funds opening new positions, 143 increasing their positions, 117 reducing their positions, and 58 closing their positions.
59% more call options, than puts
Call options by funds: $24.7M | Put options by funds: $15.6M
22% more repeat investments, than reductions
Existing positions increased: 143 | Existing positions reduced: 117
0.01% more ownership
Funds ownership: 86.47% → 86.48% (+0.01%)
0% more funds holding in top 10
Funds holding in top 10: 6 → 6 (0)
4% less funds holding
Funds holding: 388 → 373 (-15)
5% less capital invested
Capital invested by funds: $5.13B → $4.85B (-$277M)
16% less first-time investments, than exits
New positions opened: 49 | Existing positions closed: 58
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Janus Henderson Group
London,
United Kingdom
|
+$55.3M |
| 2 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
+$21.9M |
| 3 |
Invesco
Atlanta,
Georgia
|
+$20M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$14.3M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$14M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MAMU
Marathon Asset Management (UK)
London,
United Kingdom
|
-$104M |
| 2 |
Millennium Management
New York
|
-$22.1M |
| 3 |
CCM
Consonance Capital Management
New York
|
-$15.7M |
| 4 |
WT
Washington Trust
Westerly,
Rhode Island
|
-$11.5M |
| 5 |
Morgan Stanley
New York
|
-$11.5M |
GMED Hedge Fund Activity: Q4 2021 in Review
373 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Globus Medical (GMED) for Q4 2021, worth a combined $4.85B — down 5.4% from $5.13B a quarter earlier.
Sellers outnumbered buyers: 58 funds closed out of GMED and 49 opened new positions — a net loss of 9 holders — while 117 trimmed existing stakes and 143 added.
The largest buyer was Janus Henderson Group, adding an estimated $55.3M. The largest seller was Marathon Asset Management (UK), exiting entirely with an estimated $104M sold.
- 373 institutional investors held Globus Medical (GMED) as of Q4 2021, down from 388 in Q3 2021.
- Funds reported $4.85B of Globus Medical stock for Q4 2021, down 5.4% quarter-over-quarter.
- 49 funds opened new Globus Medical positions in Q4 2021 and 58 closed out, a net change of -9 holders.
- The largest Globus Medical buyer in Q4 2021 was Janus Henderson Group, an estimated $55.3M added.
- The largest Globus Medical seller in Q4 2021 was Marathon Asset Management (UK), an estimated $104M sold.
Based on aggregated 13F filings for Q4 2021.